All Compounded Products
Lack of Assurance of Sterility; potential for mold contamination
11,818 recalls · Class II, newest first
Lack of Assurance of Sterility; potential for mold contamination
Lack of Assurance of Sterility; product linked to adverse event reports of endophthalimitis eye infections and FDA inspection findings resulted in concerns regarding quality control processes
Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets by the manufacturer
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Marketed Without an Approved NDA/ANDA: The products are unapproved drugs
Subpotent drug: low fill volume in some of the capsules
Failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/or chipped tablets in the bottle.
Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.
Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.
Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.
Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.
Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.
Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.
Labeling Wrong Barcode; It may display wrong product code reflecting 0.9% Sodium Chloride Injection , USP 100 mL in MINI-BAG Plus container instead of 50 mL.
Subpotent Drug: During review of retain samples, the manufacturer observed low fill in some capsules, which was related to an issue detected with the encapsulating equipment.
Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.